Expression of microRNA in tumor cells of endmetrioid carcinoma of endometrium

Summary. Background: It is known that more than half of the genes encoding human proteins are regulated by various microRNAs (miRNAs, miR), the expression of which may be associated with various pathological conditions. At the same time, the question of assessing the relationship between the express...

Повний опис

Збережено в:
Бібліографічні деталі
Дата:2023
Автори: Buchynska, L.G., Borykun, T.V., Iurchenko, N.P., Nespryadko, S.V., Nesina, I.P.
Формат: Стаття
Мова:Англійська
Опубліковано: PH Akademperiodyka 2023
Теми:
Онлайн доступ:https://exp-oncology.com.ua/index.php/Exp/article/view/2020-4-13
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Experimental Oncology

Репозитарії

Experimental Oncology
_version_ 1856543486792171520
author Buchynska, L.G.
Borykun, T.V.
Iurchenko, N.P.
Nespryadko, S.V.
Nesina, I.P.
author_facet Buchynska, L.G.
Borykun, T.V.
Iurchenko, N.P.
Nespryadko, S.V.
Nesina, I.P.
author_sort Buchynska, L.G.
baseUrl_str
collection OJS
datestamp_date 2023-10-11T16:43:48Z
description Summary. Background: It is known that more than half of the genes encoding human proteins are regulated by various microRNAs (miRNAs, miR), the expression of which may be associated with various pathological conditions. At the same time, the question of assessing the relationship between the expression of particular miRNAs and the aggressive molecular subtype of endometrial cancer remains open. Aim of the study was to determine the relationship between the expression of miR-34a, miR-125b, miR-142 and miR-101 in endometrioid carcinomas of the endometrium (ECE) and the features of the disease course. Materials and Methods: The samples of surgical material of 51 patients with ECE (mean age 59.8 ± 7.1 years), I–III stage were investigated using morphological, immunohistochemical methods, real time polymerase chain reaction (PCR), cytofluorometry. Results: In endometrial tumors with high proliferation index (> Me), the expression of miR-34a, miR-142 and miR-125b significantly decreased (1.8, 2.7 and 1.5 times, respectively) compared with those in ECE with low proliferation index (< Me). The expression of all studied miRNAs was lower in G3 tumors and those that deeply invaded the myometrium compared to G2 carcinomas and tumors with an invasion of < 1/2 myometrium and significantly decreased in tumors of patients with low stage III compared with stage I–II. The high (> Me) microvessel density in ECE was associated with a significant decrease of miR-125b and miR-101 expression, and the presence of signs of epithelial-mesenchymal transition — with a decreased expression of miR-34a and miR-101. Conclusions: The study revealed a significant heterogeneity of expression of miR-34a, miR-125b, miR-142 and miR-101 in ECE, which is associated with changes in morphofunctional characteristics of endometrial carcinoma.
first_indexed 2025-07-17T12:15:57Z
format Article
id oai:ojs2.ex.aqua-time.com.ua:article-158
institution Experimental Oncology
language English
last_indexed 2025-07-17T12:15:57Z
publishDate 2023
publisher PH Akademperiodyka
record_format ojs
spelling oai:ojs2.ex.aqua-time.com.ua:article-1582023-10-11T16:43:48Z Expression of microRNA in tumor cells of endmetrioid carcinoma of endometrium Expression of microRNA in tumor cells of endmetrioid carcinoma of endometrium Buchynska, L.G. Borykun, T.V. Iurchenko, N.P. Nespryadko, S.V. Nesina, I.P. endometrioid endometrial carcinoma, microRNAs, miR-101, miR-125b, miR-142, miR-34a endometrioid endometrial carcinoma, microRNAs, miR-101, miR-125b, miR-142, miR-34a Summary. Background: It is known that more than half of the genes encoding human proteins are regulated by various microRNAs (miRNAs, miR), the expression of which may be associated with various pathological conditions. At the same time, the question of assessing the relationship between the expression of particular miRNAs and the aggressive molecular subtype of endometrial cancer remains open. Aim of the study was to determine the relationship between the expression of miR-34a, miR-125b, miR-142 and miR-101 in endometrioid carcinomas of the endometrium (ECE) and the features of the disease course. Materials and Methods: The samples of surgical material of 51 patients with ECE (mean age 59.8 ± 7.1 years), I–III stage were investigated using morphological, immunohistochemical methods, real time polymerase chain reaction (PCR), cytofluorometry. Results: In endometrial tumors with high proliferation index (> Me), the expression of miR-34a, miR-142 and miR-125b significantly decreased (1.8, 2.7 and 1.5 times, respectively) compared with those in ECE with low proliferation index (< Me). The expression of all studied miRNAs was lower in G3 tumors and those that deeply invaded the myometrium compared to G2 carcinomas and tumors with an invasion of < 1/2 myometrium and significantly decreased in tumors of patients with low stage III compared with stage I–II. The high (> Me) microvessel density in ECE was associated with a significant decrease of miR-125b and miR-101 expression, and the presence of signs of epithelial-mesenchymal transition — with a decreased expression of miR-34a and miR-101. Conclusions: The study revealed a significant heterogeneity of expression of miR-34a, miR-125b, miR-142 and miR-101 in ECE, which is associated with changes in morphofunctional characteristics of endometrial carcinoma. Summary. Background: It is known that more than half of the genes encoding human proteins are regulated by various microRNAs (miRNAs, miR), the expression of which may be associated with various pathological conditions. At the same time, the question of assessing the relationship between the expression of particular miRNAs and the aggressive molecular subtype of endometrial cancer remains open. Aim of the study was to determine the relationship between the expression of miR-34a, miR-125b, miR-142 and miR-101 in endometrioid carcinomas of the endometrium (ECE) and the features of the disease course. Materials and Methods: The samples of surgical material of 51 patients with ECE (mean age 59.8 ± 7.1 years), I–III stage were investigated using morphological, immunohistochemical methods, real time polymerase chain reaction (PCR), cytofluorometry. Results: In endometrial tumors with high proliferation index (> Me), the expression of miR-34a, miR-142 and miR-125b significantly decreased (1.8, 2.7 and 1.5 times, respectively) compared with those in ECE with low proliferation index (< Me). The expression of all studied miRNAs was lower in G3 tumors and those that deeply invaded the myometrium compared to G2 carcinomas and tumors with an invasion of < 1/2 myometrium and significantly decreased in tumors of patients with low stage III compared with stage I–II. The high (> Me) microvessel density in ECE was associated with a significant decrease of miR-125b and miR-101 expression, and the presence of signs of epithelial-mesenchymal transition — with a decreased expression of miR-34a and miR-101. Conclusions: The study revealed a significant heterogeneity of expression of miR-34a, miR-125b, miR-142 and miR-101 in ECE, which is associated with changes in morphofunctional characteristics of endometrial carcinoma. PH Akademperiodyka 2023-05-30 Article Article application/pdf https://exp-oncology.com.ua/index.php/Exp/article/view/2020-4-13 10.32471/exp-oncology.2312-8852.vol-42-no-4.15522 Experimental Oncology; Vol. 42 No. 4 (2020): Experimental Oncology; 289-294 Експериментальна онкологія; Том 42 № 4 (2020): Експериментальна онкологія; 289-294 2312-8852 1812-9269 10.32471/exp-oncology.2312-8852.vol-42-no-4 en https://exp-oncology.com.ua/index.php/Exp/article/view/2020-4-13/2020-4-13 Copyright (c) 2023 Experimental Oncology https://creativecommons.org/licenses/by-nc/4.0/
spellingShingle endometrioid endometrial carcinoma
microRNAs
miR-101
miR-125b
miR-142
miR-34a
Buchynska, L.G.
Borykun, T.V.
Iurchenko, N.P.
Nespryadko, S.V.
Nesina, I.P.
Expression of microRNA in tumor cells of endmetrioid carcinoma of endometrium
title Expression of microRNA in tumor cells of endmetrioid carcinoma of endometrium
title_alt Expression of microRNA in tumor cells of endmetrioid carcinoma of endometrium
title_full Expression of microRNA in tumor cells of endmetrioid carcinoma of endometrium
title_fullStr Expression of microRNA in tumor cells of endmetrioid carcinoma of endometrium
title_full_unstemmed Expression of microRNA in tumor cells of endmetrioid carcinoma of endometrium
title_short Expression of microRNA in tumor cells of endmetrioid carcinoma of endometrium
title_sort expression of microrna in tumor cells of endmetrioid carcinoma of endometrium
topic endometrioid endometrial carcinoma
microRNAs
miR-101
miR-125b
miR-142
miR-34a
topic_facet endometrioid endometrial carcinoma
microRNAs
miR-101
miR-125b
miR-142
miR-34a
endometrioid endometrial carcinoma
microRNAs
miR-101
miR-125b
miR-142
miR-34a
url https://exp-oncology.com.ua/index.php/Exp/article/view/2020-4-13
work_keys_str_mv AT buchynskalg expressionofmicrornaintumorcellsofendmetrioidcarcinomaofendometrium
AT borykuntv expressionofmicrornaintumorcellsofendmetrioidcarcinomaofendometrium
AT iurchenkonp expressionofmicrornaintumorcellsofendmetrioidcarcinomaofendometrium
AT nespryadkosv expressionofmicrornaintumorcellsofendmetrioidcarcinomaofendometrium
AT nesinaip expressionofmicrornaintumorcellsofendmetrioidcarcinomaofendometrium